CHC Healthcare Group(TW:4164)
NT$24.90+0.40 (+1.63%)
TW:4164
CHC Healthcare Group financials statements
NT$24.90
At close:+0.40 (+1.63%)
CHC Healthcare Group (4164) Ratios
CHC Healthcare Group Ratios
TW:4164's free cash flow for Q2 2026 was NT$-194.11M. For the 2026 fiscal year, TW:4164's free cash flow was decreased by NT$-187.62M and operating cash flow was NT$-6.50M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Mar 23 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 1.87 | 1.36 | 3.04 | 3.65 | 2.55 |
| Quick Ratio | 1.18 | 1.11 | 2.23 | 3.15 | 2.33 |
| Cash Ratio | 0.67 | 0.47 | 1.33 | 1.40 | 1.01 |
| Solvency Ratio | 0.11 | 0.11 | 0.15 | 0.13 | 0.13 |
| Operating Cash Flow Ratio | 0.39 | 0.03 | 0.68 | 0.62 | 0.47 |
| Short-Term Operating Cash Flow Coverage | 0.59 | 0.04 | 1.65 | 1.54 | 0.72 |
| Net Current Asset Value | NT$ -2.56B | NT$ -2.74B | NT$ -2.51B | NT$ -2.58B | NT$ -2.47B |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.35 | 0.40 | 0.38 | 0.39 | 0.40 |
| Debt-to-Equity Ratio | 0.71 | 0.91 | 0.81 | 0.82 | 0.82 |
| Debt-to-Capital Ratio | 0.42 | 0.48 | 0.45 | 0.45 | 0.45 |
| Long-Term Debt-to-Capital Ratio | 0.31 | 0.31 | 0.40 | 0.42 | 0.39 |
| Financial Leverage Ratio | 2.05 | 2.26 | 2.11 | 2.09 | 2.07 |
| Debt Service Coverage Ratio | 0.52 | 0.34 | 1.65 | 1.92 | 0.88 |
| Interest Coverage Ratio | 3.44 | 2.41 | 6.89 | 7.85 | 8.86 |
| Debt to Market Cap | 0.59 | 0.78 | 0.49 | 0.69 | 0.81 |
| Interest Debt Per Share | 24.55 | 35.02 | 32.21 | 31.65 | 32.09 |
| Net Debt to EBITDA | 3.45 | 4.30 | 2.67 | 3.38 | 3.43 |
| Profitability Margins | |||||
| Gross Profit Margin | 26.12% | 21.08% | 27.55% | 30.34% | 34.82% |
| EBIT Margin | 9.04% | 8.93% | 16.72% | 18.66% | 22.69% |
| EBITDA Margin | 24.03% | 26.50% | 32.02% | 35.45% | 41.57% |
| Operating Profit Margin | 9.04% | 6.57% | 15.82% | 18.80% | 22.70% |
| Pretax Profit Margin | 7.11% | 6.19% | 14.43% | 16.27% | 20.13% |
| Net Profit Margin | 4.24% | 4.68% | 10.80% | 11.99% | 15.64% |
| Continuous Operations Profit Margin | 5.13% | 5.07% | 10.93% | 13.08% | 15.23% |
| Net Income Per EBT | 59.58% | 75.51% | 74.87% | 73.70% | 77.71% |
| EBT Per EBIT | 78.59% | 94.23% | 91.19% | 86.51% | 88.66% |
| Return on Assets (ROA) | 1.19% | 1.18% | 3.08% | 2.78% | 3.04% |
| Return on Equity (ROE) | 2.44% | 2.67% | 6.49% | 5.81% | 6.27% |
| Return on Capital Employed (ROCE) | 3.07% | 2.21% | 5.03% | 4.75% | 5.00% |
| Return on Invested Capital (ROIC) | 1.95% | 1.45% | 3.64% | 3.67% | 3.56% |
| Return on Tangible Assets | 1.25% | 1.25% | 3.23% | 2.92% | 3.20% |
| Earnings Yield | 2.14% | 2.42% | 4.15% | 5.07% | 6.39% |
| Efficiency Ratios | |||||
| Receivables Turnover | 3.85 | 2.75 | 3.50 | 2.93 | 2.49 |
| Payables Turnover | 6.27 | 5.97 | 7.47 | 6.36 | 7.97 |
| Inventory Turnover | 1.76 | 3.22 | 2.44 | 3.92 | 4.94 |
| Fixed Asset Turnover | 0.65 | 0.60 | 0.64 | 0.50 | 0.44 |
| Asset Turnover | 0.28 | 0.25 | 0.28 | 0.23 | 0.19 |
| Working Capital Turnover Ratio | 2.45 | 1.72 | 1.36 | 1.17 | 1.03 |
| Cash Conversion Cycle | 243.97 | 185.25 | 205.20 | 160.10 | 174.61 |
| Days of Sales Outstanding | 94.79 | 132.82 | 104.18 | 124.48 | 146.59 |
| Days of Inventory Outstanding | 207.42 | 113.53 | 149.87 | 93.00 | 73.82 |
| Days of Payables Outstanding | 58.24 | 61.09 | 48.84 | 57.38 | 45.80 |
| Operating Cycle | 302.21 | 246.34 | 254.05 | 217.48 | 220.41 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 4.55 | 0.60 | 5.85 | 4.07 | 4.41 |
| Free Cash Flow Per Share | 0.71 | -1.99 | 2.35 | -0.16 | 1.14 |
| Dividend Paid and CapEx Coverage Ratio | 0.92 | 0.13 | 1.07 | 0.65 | 0.84 |
| Capital Expenditure Coverage Ratio | 1.18 | 0.23 | 1.67 | 0.96 | 1.35 |
| Operating Cash Flow Coverage Ratio | 0.19 | 0.02 | 0.18 | 0.13 | 0.14 |
| Operating Cash Flow to Sales Ratio | 0.23 | 0.03 | 0.25 | 0.22 | 0.28 |
| Free Cash Flow Yield | 1.84% | -4.76% | 3.83% | -0.37% | 2.99% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 38.50 | 41.39 | 24.08 | 19.71 | 15.66 |
| Price-to-Sales (P/S) Ratio | 1.98 | 1.94 | 2.60 | 2.36 | 2.45 |
| Price-to-Book (P/B) Ratio | 1.14 | 1.11 | 1.56 | 1.14 | 0.98 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 54.36 | -21.01 | 26.10 | -270.58 | 33.43 |
| Price-to-Operating Cash Flow Ratio | 8.46 | 70.15 | 10.49 | 10.70 | 8.62 |
| Price-to-Earnings Growth (PEG) Ratio | -38.88 | -0.69 | 1.57 | -2.18 | -3.96 |
| Enterprise Value Multiple | 11.67 | 11.60 | 10.81 | 10.04 | 9.33 |
| Enterprise Value | 12.34B | 11.07B | 13.41B | 10.59B | 9.46B |
| EV to EBITDA | 11.67 | 11.60 | 10.81 | 10.04 | 9.33 |
| EV to Sales | 2.80 | 3.07 | 3.46 | 3.56 | 3.88 |
| EV to Free Cash Flow | 77.13 | -33.37 | 34.67 | -407.76 | 52.92 |
| EV to Operating Cash Flow | 12.00 | 111.41 | 13.94 | 16.13 | 13.65 |
| Tangible Book Value Per Share | 32.70 | 35.87 | 37.36 | 35.90 | 36.19 |
| Shareholders’ Equity Per Share | 33.78 | 37.80 | 39.27 | 38.06 | 38.75 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.28 | 0.18 | 0.24 | 0.20 | 0.23 |
| Revenue Per Share | 19.47 | 21.59 | 23.58 | 18.43 | 15.54 |
| Net Income Per Share | 0.82 | 1.01 | 2.55 | 2.21 | 2.43 |
| Tax Burden | 0.60 | 0.76 | 0.75 | 0.74 | 0.78 |
| Interest Burden | 0.79 | 0.69 | 0.86 | 0.87 | 0.89 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.17 | 0.15 | 0.12 | 0.14 | 0.15 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 5.52 | 0.45 | 1.72 | 1.36 | 1.41 |
Currency in TWD
